Induction of apoptosis in an estrogen-responsive mouse Leydig tumor cell by leukotriene

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 225-232

  Goto, H G ^a,b   Nishizawa, Yasuko ^a,b   Katayama, H ^a,b   Murashima, T ^a,c   Yamasaki, M ^a,b   Tanigaki, Y ^a   Kimura, S ^c   Fushiki, S ^d   Nishizawa, Y ^d,e  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

5 Lipoxygenase; Estrogen; Growth; Leukotriene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BENZOQUINONE DERIVATIVE; DOCEBENONE; ESTRADIOL; LEUKOTRIENE D4; MESSENGER RNA;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL GROWTH; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LEYDIG CELL TUMOR; MALE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BENZOQUINONES; CELL GROWTH PROCESSES; ESTRADIOL; LEUKOTRIENE D4; LEYDIG CELL TUMOR; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 39049191810     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.225     Document Type: Article

References (35)

1. Nishizawa Y, Sato B, Miyashita Y, Tsukada S, Hirose T, Kishimoto S and Matsumoto K: Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture. Endocrinology 122: 227-235, 1988. (Pubitemid 18027607)
2. Ara G and Teicher B: Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins Leukot Essent Fatty Acids 54: 3-16, 1996. (Pubitemid 26083090)
3. Zeldin D: Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062, 2001.
4. FitzGerald GA: Prostaglandins, aspirin, and related compounds. In: Cecil Textbook of Medicine. Ausiello D (ed). Saunders, Philadelphia, pp155-161, 2004.
5. Phillips R, Wallace MH, Lynch P, Hawk E, Gordon G, Saunders B, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su L, Sherman J, Kellof G, Levin B and Steinbach G: A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50: 857-860, 2002. (Pubitemid 34539050)
6. Steinbach G, Lynch P, Phillips R, Wallace MH, Hawk E, Gordon G, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su L and Levin B: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 1946-1952, 2000. (Pubitemid 30419089)
7. Levy G: Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 11: 234-247, 1997.
8. Janne P and Mayer R: Chemoprevention of colorectal cancer. N Engl J Med 342: 1960-1968, 2000. (Pubitemid 30419092)
9. Piazza G, Rahm A, Krutzsch M, Sperl G, Paranka N, Gross P, Brendel K, Burt R, Alberts D and Pamukcu R: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110-3116, 1995.
10. Shureiqi I and Lippman SM: Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61: 6307-6312, 2001. (Pubitemid 32783228)
11. He T, Chan T, Vogelstein B and Kinzler K: PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345, 1999. (Pubitemid 29519912)
12. Yao R, Rioux N, Castonguay A and You M: Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res 26: 731-742, 2000. (Pubitemid 32044588)
13. Nishizawa Y, Nishii K, Nishizawa Y, Koga M, Kishimoto S, Matsumoto K and Sato B: Effects of estrogen on cell proliferation and leukotriene formation in transformed mouse Leydig cells cultured under serum-free conditions. Cancer Res 50: 3866-3871, 1990. (Pubitemid 20225598)
14. Nishizawa Y, Nishii K, Kishimoto S, Matsumoto K and Sato B: Regulatory role of arachidonic acid-derived metabolites for proliferation of transformed murine Leydig cell in serum-free culture condition. Anticancer Res 10: 317-322, 1990. (Pubitemid 20187270)
15. Nishii K, Nishizawa Y, Nishizawa Y, Matsumoto K and Sato B: Inhibition of murine transformed Leydig cell proliferation by leukotrienes in serum-free culture. Cancer Res 51: 5573-5578, 1991.
16. Nishizawa Y, Yamamoto T, Taniguchi H and Sato B: Effects of estrogen and leukotrienes on anchorage-independent growth of transformed mouse Leydig cells under serum-free condition. Steroid Biochem (Life Sci Adv) 11: 23-28, 1992.
17. Sato B, Hirose T, Kasayama S, Takabayashi H, Koga M and Nishizawa Y: Transformed murine Leydig cells in serum-free culture: useful model for analysis of steroid hormone-induced cell growth and cell morphology (Review). Int J Oncol 1: 415-423, 1992.
18. Nishizawa Y, Nishizawa Y, Yamamoto T, Terada N, Amakata Y, Matsumoto K and Sato B: Progression of mouse transformed Leydig cells from estrogen-sensitive to estrogen-insensitive growth phenotype concomitant with loss of leukotriene D4 receptor. Int J Oncol 5: 1077-1084, 1994. (Pubitemid 24318737)
19. Nishizawa Y, Yamamoto T, Terada N, Fushiki S, Amakata Y and Nishizawa Y: Effects of antiallergic drugs on the proliferation of estrogen-sensitive mouse Leydig cell line. Anticancer Res 16: 1241-1246, 1996.
20. Henning R, Ding X-Z, Tong W-G, Schneider MB, Standop J, Friess H, Buchier MW, Pour PM and Adrian TE: 5-Lipoxygenase and leukotriene B4 receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol 161: 421-428, 2002. (Pubitemid 36142151)
21. Tong W-G, Ding X-Z, Henning R, Witt RC, Standop J, Pour PM and Adrian TE: Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and incuces apoptosis in human pancreatic cancer cells. Clin Cancer Res 8: 3232-3242, 2002. (Pubitemid 35155036)
22. Ashida Y, Saijo T, Kuriki H, Makino H, Terao S and Maki Y: Pharmacological profile of AA-861, a Lipoxygenase inhibitor. Prostaglandins 26: 955-972, 1983. (Pubitemid 14165834)
23. Alanko J, Sievi E, Lahteenmaki T, Mucha I, Vapaatalo H and Parantainen J: Catechol estrogens as inhibitors of leukotriene synthesis. Biochem Pharmacol 55: 101-104, 1998. (Pubitemid 28101991)
24. Kemal C, Louis-Flamberg P, Krupinski-Olsen R and Sh A: Reductive inactivation of soybean lipoxygenase by catechols: a possible mechanism for regulation of lipoxygenase activity. Biochemistry 26: 7064-7072, 1987. (Pubitemid 18006254)
25. Dietsch V, Kalf GF and Hazel BA: Induction of granulocytic differentiation in myeloblasts by 17-beta-estradiol involves the leukotriene D4 receptor. Receptors Signal Transduct 6: 63-75, 1996.
26. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez M and Mulshine JL: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813, 1996. (Pubitemid 26057100)
27. Buckman D, Hubbard N and Erickson K: Eicosanoids and linoleate-enhanced growth of mouse mammary tumor cells. Prostaglandins Leukot Essent Fatty Acids 44: 177-184, 1991.
28. Gati I, Bergstrom M, Csoka K, Muhr C and Carlsson J: Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines. Prostaglandins Leukot Essent Fatty Acids 40: 117-124, 1990. (Pubitemid 20180070)
29. Rioux N and Castonguay A: Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 19: 1393-1400, 1998. (Pubitemid 28409837)
30. Ohd JF, Nielsen CK, Campbell J, Landberg G, Lofberg H and Sjolander A: Expression of the leukotriene D4 receptor CysLT1, COX-2 and other cell survival factors in colonrectal adenocarcinomas. Gastroentorology 124: 57-70, 2003. (Pubitemid 36055339)
31. Nielsen C, Campbell J, Ohd J, Morgelin M, Riesbeck K, Landberg G and Sjolander A: A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65: 732-742, 2005. (Pubitemid 40220345)
32. Paruchuri S, Mezhybovska M, Juhas M and Sjolander A: Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells. Oncogene: May 2022 [Epub ahead of print], 2006.
33. Gualde N, Atluru D and Goodwin J: Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J Immunol 134: 1125-1129, 1985. (Pubitemid 15157313)
34. Werner E, Walenga R, Dubowy R, Boone S and Stuart M: Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid. Cancer Res 45: 561-563, 1985. (Pubitemid 15161047)
35. van Hilten J, Ben Efraim S, Zijlstra F and Bonta I: Leukotriene C4 is an essential 5-lipoxygenase intermediate in A23187-induced macrophage cytostatic activity against P815 tumor cells. Prostaglandins Leukot Essent Fatty Acids 39: 283-290, 1990. (Pubitemid 20135555)